Delphinus Medical Technologies
PrivateLast Round
Convertible Debt
Apr 3, 2025
Total Funding Raised
$153.66M
Company Overview
Delphinus Medical Technologies is a medical device company that develops and commercializes the SoftVue 3D whole-breast ultrasound tomography system for breast cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delphinus Medical Technologies Comparables
Compare Delphinus Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iVu Imaging Corporation | 94% | |
| Lily MedTech Inc. | 85% | |
| QT Imaging Holdings, Inc. | 85% |
Delphinus Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 3, 2025 | ||||
| Debt | Aug 22, 2023 | ||||
| Debt | Jun 22, 2023 | ||||
| Series D | Sep 29, 2022 | ||||
| Series C | Sep 10, 2015 | ||||
Series B | Sep 3, 2013 |
Delphinus Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Coast Technology Investors | Series A, Series D, Series B, Series C |
| Arboretum Ventures | Series D, Series C, Series B, Series A |
| Waycross Ventures | Series D, Series C |
| Beringea | Series A, Series D, Series C, Series B |
| Venture Investors LLC | Series D, Series C |
| Trinity Capital | Debt |
| Hopen Life Science Ventures | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2023
$12M round led by Trinity Capital.
- Sep 29, 2022
$30M round with participation from Beringea and Arboretum Ventures.
Delphinus Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delphinus Medical Technologies's valuation, stock price, and market status.
Is Delphinus Medical Technologies a public or private company?
Delphinus Medical Technologies is a private company.
What is the current stock price of Delphinus Medical Technologies?
Delphinus Medical Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Delphinus Medical Technologies worth (valuation)?
Valuation information for Delphinus Medical Technologies is not publicly available.
Can I buy Delphinus Medical Technologies stock?
Delphinus Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delphinus Medical Technologies's last funding round?
Delphinus Medical Technologies's most recent funding round was Series D Extension on April 3, 2025.
Who are the main investors in Delphinus Medical Technologies?
Key investors in Delphinus Medical Technologies include Arboretum Ventures, Beringea, Venture Investors LLC, Trinity Capital.
Will Delphinus Medical Technologies IPO soon?
No public IPO plans have been announced for Delphinus Medical Technologies.
How can I track Delphinus Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delphinus Medical Technologies's secondary market activity and sign up for updates.